SCHEMBL4763131

SCHEMBL4763131

O=C(Nc1ccc(F)cc1F)c1cnccn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
KDM4E B2RXH2 2/20 0.62
HDAC3 O15379 1/20 0.58
HDAC1 Q13547 1/20 0.58
HDAC2 Q92769 1/20 0.58
HDAC8 Q9BY41 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
CTDSP1 Q9GZU7 1/20 0.58
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
MCL1 Q07820 1/20 0.56
GAA P10253 1/20 0.53
ALDH1A1 P00352 3/20 0.52
ALOX15 P16050 2/20 0.52
TSHR P16473 2/20 0.52
MAPT P10636 1/20 0.52
LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18086518 0.89 HDAC3 (0.67) HTTSMN1; SMN2KDM4EHDAC3HDAC1
SCHEMBL10415432 0.82 GRM4 (0.63) HTTSMN1; SMN2HDAC3HDAC1HDAC2
SCHEMBL30763162 0.82 HDAC3 (0.74) HTTSMN1; SMN2HDAC3HDAC1HDAC2
SCHEMBL21595522 0.82 HDAC3 (0.74) HTTSMN1; SMN2HDAC3HDAC1HDAC2
SCHEMBL4479064 0.78 ROCK2 (0.57) HTTSMN1; SMN2KDM4EKMT2AALOX15
SCHEMBL12010995 0.77 RAB9A (0.64) HTTSMN1; SMN2MEN1KMT2ACTDSP1
SCHEMBL29393380 0.77 GAA (0.76) SMN1; SMN2HDAC3HDAC1HDAC2NPC1
SCHEMBL4483530 0.77 THRB (0.53) HTTSMN1; SMN2MEN1KMT2ANPC1
SCHEMBL14062228 0.77 GAA (0.76) SMN1; SMN2HDAC3HDAC1HDAC2NPC1
SCHEMBL28075797 0.77 GSK3A (0.66) HTTSMN1; SMN2KDM4EHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937682-A1 MET KINASE INHIBITORS Brystol-Myers Squibb Company (US) 2008-07-02 EP disclosed
WO-2007041379-A1 MET KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-04-12 WO disclosed